Can't wait sick of their gloating:let'em find toxic chemicals or something sinister to short, just feels unethical to pick on biotechs to short b/c they're high-investment/heavy R&D/ require highly skilled scientists and strict protocols and gov't reg's over time -- to try and save lives, or make them better. Legal isn't always ethical anyway I have NO sympathy for the shorts. -- Neuvax PhIII bombed but the pipeline is being well-received by the scientific community.
Ended @$.00 despite a roller-coaster day as high as $4.75, hope any shorts who hoped to take it below the $3.20 of last week are feeling the burn.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.